D-0787-2020 Class II Terminated
FDA drug recall D-0787-2020 was initiated by Sun Pharmaceutical Industries, Inc. on Jan 14, 2020 and is designated Class II. Reason for recall: cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot. The recall status is terminated (terminated Aug 31, 2020).
Recall details
- Product Type
- Drugs
- Report Date
- Jan 22, 2020
- Initiation Date
- Jan 14, 2020
- Termination Date
- Aug 31, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Testosterone Cypionate for Injection, USP, 1,000 mg/10 mL (100 mg/mL), 10 mL Multiple Dose Vial (NDC 62756-017-40), Rx only, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceuticals, Industries, Ltd., Gujarat, India
Reason for recall
cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.
Distribution pattern
Product was distributed throughout the United States.
Code information
JKT0933A, JKT0935A, JKT1062A exp Mar-20; JKT1425A, JKT1483A exp Apr-20; JKT1575A, JKT1729A, JKT1730A, JKT1728A exp May-20 JKT2002A exp Jun-20; JKT3216A, JKT3217A exp Sep-20; JKT3589A, JKT3590A, JKT3626A exp Oct-20; JKT3864A, JKT3935A exp Dec-20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0787-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026